mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.03 |